PharmaMar begins phase II 'Basket' trial to evaluate safety, efficacy of PM1183 in ad
PharmaMar announced today the start of a multicenter, international, open-label, exploratory phase II "Basket" trial (NCT02454972) to evaluate the efficacy and safety of the anticancer agent PM1183 (lurbinectedin) in advanced solid tumors.